EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Liver Transplantation 2023: Status Report, Current and Future Challenges

Norah A Terrault, Claire Francoz, Marina Berenguer, Michael Charlton, Julie Heimbach

Clinical Gastroenterology and Hepatology · 2023-07 · 21 (8) · 2150-2166

DOI: 10.1016/j.cgh.2023.04.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-07. Verfasst von Norah A Terrault und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, California. Electronic address: terrault@usc.edu. Hauptthemen laut MEDLINE: Liver Transplantation, End Stage Liver Disease, Carcinoma, Hepatocellular, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 336-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation offers live-saving therapy for patients with complications of cirrhosis and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and innovations aimed at increasing the number of usable deceased donors as well as alternative donor sources are a major focus. The etiologies of cirrhosis are shifting over time, with more need for transplantation among patients with alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease and less for viral hepatitis, although hepatitis B remains an important indication for transplant in countries with high endemicity. The rise in transplantation for alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease has brought attention to how patients are selected for transplantation and the strategies needed to prevent recurrent disease. In this review, we present a status report on the most pressing topics in liver transplantation and future challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationEnd Stage Liver DiseaseCarcinoma, HepatocellularLiver Diseases, AlcoholicNon-alcoholic Fatty Liver DiseaseLiver NeoplasmsHumansLiver CirrhosisFibrosis

Stichwörter der Autor:innen

Alcohol-associated Liver DiseaseAlcoholic HepatitisAllocationEquityExtended Criteria DonorFatty LiverHepatitis BHepatitis CLiver CancerMELDMachine PerfusionXenotransplantation

Autor:innen und Institutionen

  • Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, California. Electronic address: terrault@usc.edu.
  • Liver Intensive Care and Liver Transplantation Unit, Hepatology, Hospital Beaujon, Clichy, France.
  • Hepatology and Liver Transplantation Unit, Hospital Universitario la Fe - IIS La Fe Valencia; CiberEHD and University of Valencia, Valencia, Spain.
  • Transplantation Institute, University of Chicago, Chicago, Illinois.
  • William von Liebig Center for Transplantation, Mayo Clinic Rochester, Minnesota.

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Terrault, N. A., Francoz, C., Berenguer, M., Charlton, M., & Heimbach, J. (2023). Liver Transplantation 2023: Status Report, Current and Future Challenges. Clinical Gastroenterology and Hepatology, 21(8), 2150-2166. https://doi.org/10.1016/j.cgh.2023.04.005

Vancouver

Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J. Liver Transplantation 2023: Status Report, Current and Future Challenges. Clinical Gastroenterology and Hepatology. 2023;21(8):2150-2166. doi:10.1016/j.cgh.2023.04.005

BibTeX
@article{Terrault2023,
  author = {Terrault, Norah A and Francoz, Claire and Berenguer, Marina and Charlton, Michael and Heimbach, Julie},
  title = {Liver Transplantation 2023: Status Report, Current and Future Challenges},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {8},
  pages = {2150--2166},
  doi = {10.1016/j.cgh.2023.04.005}
}
Kostenlos starten →